PTOIAIA/‘I4 (07-14)
`Approved for use through 04/30/2017. OMB 0651—0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`46682-701501
`
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number
`
`
`
`OPHTHALMIC COMPOSITION
`
`
`
`
`
`
`
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`
`
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`
`
`TItIe of Invention
`
`
`
`
`
`Secrecy Order 37 CFR 5.2
`
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`
`
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`Inventor
`Legal Name
`
`1
`
`
`
`'
`
`‘
`I
`
`;Family Name
`Middle Name
`Given Name
`"—
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`Suffix
`
`Mailing Address of Inventor:
`
`14051 Caminito Vistana
`
`San Diego
`
`92130
`
`State/Province
`CA 0')
`Country i
`
`CA
`
`Remove
`
`Address 1
`
`Address 2
`City
`Postal Code
`
`Inventor
`
`2
`
`Legal Name
`
`Prefix Given Name
`
`Middle Name
`
`;Family Name
`
`InE X
`I
`
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`City
`Rancho Santa Fe
`State/Province
`Country of Residencei
`US
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`PO Box 676250
`
`City
`Postal Code
`
`Rancho Santa Fe
`92067
`
`Inventor
`
`3
`
`Legal Name
`
`State/Province
`4C4 co
`Country i
`
`CA
`
`Prefix— Middle Name
`
`Family Name
`
`Suffix
`
`Residence Information (Select One)
`
`(9 US Residency 0 Non US Residency 0 Active US Military Service
`
`EFS Web 2.2.12
`
`

`

`PTO/AlA/‘I4 (07-14)
`Approved for use through 04/30/2017. 0MB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`of information unless it contains a valid OMB control number.
`Underthe PapenNork Reduction Act of 1995, no persons are required to respond to a collection
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`OPHTHALMIC COMPOSITION
`
`Title of Invention
`
`Attorney Docket Number
`
`Application Number
`
`46682-701501
`
`
`
`
`
`
`
`Carlsbad State/Province
`
`of Residence I
`
`
`Mailing Address of Inventor:
`7205 Aviara Drive
`Address 1
`
`Address 2
`
`
`
`City
`
`Carlsbad
`
`Postal Code
`
`92011
`
`State/Province
`S
`
`U
`
`CA
`
`Inventor Information blocks m
`Inventors Must Be Listed - Additional
`All
`generated within this form by selecting the Add button.
`
`ay be
`
`Add
`
`
`
`
`
`
`Correspondence Information:
`
`t‘Du-v-(D o-v-3' (D OO .7“mtn'0 O3 D.m 3 O(D 9—,.O '13It!
`[11E.{DH m 53' (D"l O CtnFF03 m w Z G 30'fl)'1 O '1 OO3
`tion section below.
`'9.
`For further information see 37 CFR 1.33(a).
`
`
`
`
`
`
`[:I An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`
`
`Email Address
`patentdocket@wsgr.com
`
`
`Addams"
`
`
`
`
`
`
`
`
`
`
`Application Information:
`
`Title of the Invention
`
`Attorney Docket Number
`Application Type
`
`OPHTHALMIC COMPOSITION
`
`46682-701501
`
`Nonprovisional
`
`Subject: Matter
`
`
`
`Small Entity Status Claimed
`
`
`
`Suggested Figure for Publication (if any)
`
`
`
`
`
`
`
`
`Application number of the previously
`filed application
`
`
`
`
`Publication Information:
`
`
`
`
`
`Total N umber of Drawing Sheets (if any)
`
`
`Filing By Reference :
`
`
`
`
`‘37 CFR I.57(a). Do not complete this section if
`
`ete this section when filing an application by reference under 35 U.S.C. 111(c) and
`Only comp
`
`papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`application
`on" and ”Foreign Priority Information”).
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Informati
`
`
`
`
`poses of a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`For the pur
`reference to the previously filed application, subject to conditions and requirements of 37 CFR I .S7(a).
`Intellectual Property Authority or Country i
`Filing date (YYYY-MM-DD)
`
`
`
`
`[:1 Request Early Publication (Fee required at time of Request 37 CFR 1.21
`
`Request Not to Publish. I hereby request that the attached application not be published under
`
`
`application has not and will not be the
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached
`'nternational agreement, that requires
`subject of an application filed in another country, or under a multilateral
`
`publication at eighteen months after filing.
`EFS Web 2.2.12
`
`

`

`PTO/AlA/14 (07-14)
`Approved for use through 04/30/2017. OMB 0651—0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`of information unless it contains a vaIid OMB control number.
`
`Attorney Docket Number
`
`46682—701501
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`Title of Invention
`
`OPHTHALMIC COMPOSITION
`
`Representative lnfOrmation:
`
`
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`ation in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`this inform
`If both sections are completed the customer
`
`Either enter Customer Number or complete the Representative Name section below.
`Number \iIill be used for the Representative Information during processing.
`
`
`
`
`
`
`Please Select One:
`
`6) Customer Number
`
`0 US Patent Practitioner
`
`Customer Number
`
`0 Limited Recognition (37 CFR 11.9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Domestic Benefit/National Stage Information:
`
`0, 121, 365(c), or 386(c) or indicate National
`This secti n allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 12
`Stage ent
`from a PCT application. Providing this information in the application data sheet constitutes the specific reference
`required y 35 U.S.C. 1 19(e) or 120, and 37 CFR 1.78.
`please leave the application number blan
`When referring to the current application,
`Prior Application Status
`Application Number
`
`
`
`k.
`
`
`
`
`
`Prior Applicatio
`
`n Number
`
`147261 89
`
`Filing Date (YYYY-MM-DD)
`2015—05-29
`
`3.9a
`
`Filing Date (YYYY-MM-DD)
`
`2015-06-23
`aE(D
`
`Filing Date (YYYY-MM-DD)
`2014—06-24
`
`Filing Date (YYYY-MM-DD)
`2014—12—23
`
`3.9a
`
`Filing Date (YYYY-MM-DD)
`2015-04-23
`
`Add
`
`
`
`
`
`
`
`
`
`
`P
`
`rior Application Status
`Application Number
`
`Prior Application Status
`Application Number
`
`Prior IApplication Status
`Appl cation Number
`
`P
`
`rior ' ppIication Status
`
`Appl cation Number
`
`Prior Applicatio
`
`n Number
`
`PCTUS1537249
`
`Prior Applicatio
`62016502
`
`n Number
`
`Prior Applicatio
`
`n Number
`
`62096433
`
`Prior Applicatio
`
`n Number
`
`1472613
`
`Claims benefit of provisional
`
`62151926
`
`Additional Domestic Benefit/National Stage Data may be generated within th
`by seleriting the Add button.
`oreigin Priority Information:
`
`
`
`sform
`
`F
`
`
`EFS Web 2.
`
`.12
`
`
`
`

`

`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`46682-701501
`
`
`
`Applic tion Data Sheet 37 CFR 1.76
`
` Attorney Docket Number
`
`Application Number
`
`PTO/AIN14 (07-14)
`Approved for use through 04/30/2017. OMB 0651—0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Title of lfivention
`OPHTHALMIC COMPOSITION
`
`
`constitutes¥theclaimforpriorityasrequiredby35U.S.C.119(b)and37CFR1.55_. Whe
`
`
`
`
`
`
`
`
`
`
`This sectio allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`n prion'ty is claimed to a foreign application
`le for retrieval under the priority document exchange program (PDX) lthe information will be used by the Office to
`that is eligi
`rogram, applicant bears the ultimate
`automatica Iy attempt retrieval pursuant to 37 CFR 1.55(i)(1) and (2). Under the PBX p
`from the participating foreign intellectual
`for ensuring that a copy of the foreign application is received by the Office
`responsibil
`property 0 ice, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`Add but on.
`
`
`
`
`
`‘efore March 16, 2013 and (2) also
`
`This application (1) claims priority to or the benefit of an application filed b
`an effective filing date on or after March
`cont-ins, or contained at any time, a claim to a claimed invention that has
`
`
`[:1 16, 013.
`
`
`9 this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`NO E: By providin
`
`
`AIA.
`16,
`. 013, will be examined under the first inventor to file provisions of the
`
`
`
`
`
`Autho ization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`
`
`
`
`
`
`
`EFS Web 2.
`
`.12
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`PTO/AIN14 (07-14)
`Approved for use through 04/30/2017. OMB 0651—0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`Applic
`
`_
`tion Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`
`
`
`OPHTHALMIC COMPOSITION
`
`Attorney Docket Number
`_
`,
`
`46682-701501
`
`~
`
`
`
`
`
`
`
`
`
`
`
`
`-__
`
`
`
`-_
`
`
`m ‘ ddress Information For Applicant:
`’
`I
`I
`
`
`
`
`
`
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed acc 55 to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not w sh the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the insta t patent application is filed to have access to the instant patent application.
`
`In accorda ce with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the i stant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims prio 'ty under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1. 15 has been filed in the instant patent application; and 3) any U.S. application-as—filed from which benefit is
`sought in t e instant patent application.
`
`Inaccorda‘vcewith37CFR1.14(c),accessmaybeprovidedtoinformationconcerningthedate0ffilingthisAuthorization.
`
`
`444:7444
` Providing assignment information in this section does not substitute for compliance wit any requirement of part 3 of Title 37 of CFR
`
`
`
`
`
`1
`Applica t
`If the appli - ant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The inform tion to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`
`
`1.43; or th name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`
`who othe
`ise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`
`
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise ShOWS sufficient
`
`
`
`proprietarylinterest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`this section.
`.
`~
`
`
`ide tifiedi
`“
`
`If the Applicant is an Organization check here.
`
`Fax Number
` Phone umber
`.
`
`EFS Web 2.
`
`.12
`
`
`
`

`

`
`
`Approved for use through 04/30/2017. OMB 0651-0032
`‘
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`i
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection‘ of information unless it contains a valid OMB control number.
`
`
`
`
` a
`
`tron Data Sheet 37 CFR 1.76
`
`
`
`
`Title of l- OPHTHALMIC COMPOSITION
`
`
`-—
`
`
`
`,
`
`_
`
`PTO/AlA/14 (07-14)
`
`l
`
`Additiona Applicant Data may be generated within this form by selecting the Add button.
`
`Assig ee information including Non-Applicant Assignee Information:
`
`
`.
`
`Providing ssignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an asignment recorded by the Office.
`‘
`
`
`
`Complete his section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`
`applicatio publication . An assignee-applicant identified in the "Applicant information" section will appear on the patent application
`
`publicatio as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`
`
`patent ap- lication publication.
`-—
`If the Asignee or Non-Applicant Assignee is an Organization check here.
`[I
`
`Prefix _— Middle Name
`Family Name
`Suffix
`
`
`
` A
`ddress Information For Assignee including Non-Applicant Assignee:
`
`Addres.
`
`Addres 2
`
`89.:Q 3
`
`F'-
`
`Email A-
`
`Additionl Assignee or Non-Applicant Assignee Data may be generated within this form by
`selectin- the Add button.
`
`
`Signa lure:
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifica ions.
`
`
`
`
`
`Signat fl/Xiaofan Yang/
`
`Date (YYYY-MM-DD)
`
`2015-09-18
`
`Additio al Signature may be generated within this form by selecting the Add button.
`
`EFS Web 2.’ .12
`
`

`

`
`
`PTO/AlA/14 (07-14)
`Approved for use through 04/30/2017. OMB 0651—0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number
`46682-701501
`Mtion Data Sheet 37 CFR 1.76
`
`
`
`
`
`
`
`
`
`OPHTHALMIC COMPOSITION
`
`This colle tion of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (nd by the USPTO to process) an application. Confidentiality is governed by 135 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet fo
`to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief information Officer, U.S. Patent and
`Tradema k Office, U.S. Department of Commerce, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLE ED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2. ‘.12
`
`
`
`

`

`Privacy Act Statement
`
`The inform tion provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of lnfonnation Act (5 U.S.C. 552)
`nd the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`hether the Freedom of Information Act requires disclosure of these records.
`
`‘ record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`istrative tribunal, including disclosures to opposing counsel in the course of settlement‘negotiations.
`
`admi
`
`3.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`i dividual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`
`The Privac Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent aplication or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this info
`ation is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by th US. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`if you do not
`furnish the requested information, the US. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in te mination of proceedings or abandonment of the application or expiration of the patent.
`
`SPTO becomes aware of a violation or potential violation of law or regulation.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`nrder to perform a contract Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`mended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an international Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`s a routine use, to the International Bureau of the World intellectual Property Organization, pursuant to the Patent C o o p eration Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`eview (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 21‘8(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`nuring an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`nder authority of 44 U.S.C. 2904 and 2906. mm disclosure shall be made in accordance with the
`. SA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`l-isclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the pdblic after either publication of the application pursuan
`o 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`FR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings Were
`erminated and which application is referenced by either a published application, an application open to public inspections or an issued
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`
`EFS Web 2.2 12
`
`